BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31317187)

  • 1. The long-term rapid increase in incidence of adenocarcinoma of the kidney in the USA, especially among younger ages.
    Zheng T; Zhu C; Bassig BA; Liu S; Buka S; Zhang X; Truong A; Oh J; Fulton J; Dai M; Li N; Shi K; Qian Z; Boyle P
    Int J Epidemiol; 2019 Dec; 48(6):1886-1896. PubMed ID: 31317187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time trend and the age-period-cohort effect on the incidence of histologic types of lung cancer in Connecticut, 1960-1989.
    Zheng T; Holford TR; Boyle P; Chen Y; Ward BA; Flannery J; Mayne ST
    Cancer; 1994 Sep; 74(5):1556-67. PubMed ID: 8062189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rising incidence of renal cell cancer in the United States.
    Chow WH; Devesa SS; Warren JL; Fraumeni JF
    JAMA; 1999 May; 281(17):1628-31. PubMed ID: 10235157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010.
    King SC; Pollack LA; Li J; King JB; Master VA
    J Urol; 2014 Jun; 191(6):1665-70. PubMed ID: 24423441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-period-cohort analysis of renal cell carcinoma in United States adults.
    Tyson MD; Humphreys MR; Parker AS; Thiel DD; Joseph RW; Andrews PE; Castle EP
    Urology; 2013 Jul; 82(1):43-7. PubMed ID: 23706585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time trends in the incidence of renal carcinoma: analysis of Connecticut Tumor Registry data, 1935-1989.
    Katz DL; Zheng T; Holford TR; Flannery J
    Int J Cancer; 1994 Jul; 58(1):57-63. PubMed ID: 8014016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.
    Aschebrook-Kilfoy B; Ward MH; Sabra MM; Devesa SS
    Thyroid; 2011 Feb; 21(2):125-34. PubMed ID: 21186939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935-1988.
    Zheng T; Mayne ST; Boyle P; Holford TR; Liu WL; Flannery J
    Cancer; 1992 Aug; 70(4):840-9. PubMed ID: 1643616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis.
    Syed JS; Nguyen KA; Holford TR; Hofmann JN; Shuch B
    Cancer; 2019 Jan; 125(2):232-238. PubMed ID: 30561791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between renal cell carcinoma and non-Hodgkin's lymphoma.
    Rabbani F; Russo P
    Urology; 1999 Jul; 54(1):28-33. PubMed ID: 10414722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate use and risk of renal cell carcinoma: A population-based case-control study.
    Chung BI; Hellfritzsch M; Ulrichsen SP; Sørensen HT; Ehrenstein V
    Basic Clin Pharmacol Toxicol; 2019 May; 124(5):642-646. PubMed ID: 30472809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II-An Updated Analysis of SEER-Medicare Data.
    Shih YT; Xu Y; Chien CR; Kim B; Shen Y; Li L; Geynisman DM
    Pharmacoeconomics; 2019 Dec; 37(12):1495-1507. PubMed ID: 31286464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986-2007.
    De P; Otterstatter MC; Semenciw R; Ellison LF; Marrett LD; Dryer D
    Cancer Causes Control; 2014 Oct; 25(10):1271-81. PubMed ID: 25034462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based study of renal cell carcinoma and prostate cancer in the same patients.
    Barocas DA; Rabbani F; Scherr DS; Vaughan ED
    BJU Int; 2006 Jan; 97(1):33-6. PubMed ID: 16336324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cigarette smoking and renal cell carcinoma risk among black and white Americans: effect modification by hypertension and obesity.
    Cote ML; Colt JS; Schwartz KL; Wacholder S; Ruterbusch JJ; Davis F; Purdue M; Graubard BI; Chow WH
    Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):770-9. PubMed ID: 22426145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Renal-Cell Carcinoma Incidence and Mortality in the United States in the Last 2 Decades: A SEER-Based Study.
    Saad AM; Gad MM; Al-Husseini MJ; Ruhban IA; Sonbol MB; Ho TH
    Clin Genitourin Cancer; 2019 Feb; 17(1):46-57.e5. PubMed ID: 30391138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.
    Merrill RM; Capocaccia R; Feuer EJ; Mariotto A
    Int J Epidemiol; 2000 Apr; 29(2):197-207. PubMed ID: 10817114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004-2009.
    Houston KA; Henley SJ; Li J; White MC; Richards TB
    Lung Cancer; 2014 Oct; 86(1):22-8. PubMed ID: 25172266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International variations and trends in renal cell carcinoma incidence and mortality.
    Znaor A; Lortet-Tieulent J; Laversanne M; Jemal A; Bray F
    Eur Urol; 2015 Mar; 67(3):519-30. PubMed ID: 25449206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal cell carcinoma in the pediatric population: Results from the California Cancer Registry.
    Silberstein J; Grabowski J; Saltzstein SL; Kane CJ
    Pediatr Blood Cancer; 2009 Feb; 52(2):237-41. PubMed ID: 18937317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.